Document Packaging Safety Seed-To-Sale 
Cannabis Law Report
FEBRUARY 13, 2022
The Program Specialist 2 (Cannabis) positions will perform applicant and licensee inspection of physical facilities, adherence to program regulations, development of guidance documents and statement of findings and other duties ensuring licensees are complying with public health and safety best practices. Full Job Description.
WeedAdvisor
OCTOBER 21, 2019
In its quest to create an effective framework, Mexico looked at Canada for guidance and pondered key issues like government vs. private control of distribution, production, and sales. Second, recreational use for individuals, shared use and sales – the core of marijuana legalization – will be allowed. Fair Regulation”. .
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Canna Law Blog
AUGUST 11, 2019
A smaller but growing number of states also regulate the sale of products derived from hemp. SB 1020 provides for the creation of a plan for regulating the cultivation of hemp, pursuant to the 2018 Farm Bill, and legalizes the retail sales of hemp extract. This week we head south to Florida. percent on a dry-weight basis.
Cannabis Law Report
FEBRUARY 17, 2022
Mycotoxins are contaminants that licensees are required to screen for to uphold public health, safety, and welfare. Among the actions required under the quarantine order, ACK Natural, LLC was directed to immediately post the document to all public entrances of its establishment. PRESS RELEASE.
Cannabis Law Report
NOVEMBER 11, 2021
Similarly, the MRTA requires the CCB “[t]o fix by rule and regulation the standards and requirements of cultivation, processing, packaging, marketing, and sale of. ” The CCB intends to address the sale of such products in the adult-use regulations. no later than six months after the effective date of the MRTA.”
Cannabis Law Report
OCTOBER 6, 2021
Flora Pharma expects to fast track traditional FDA and NHS timelines by running phase trials in parallel (in vitro, in vivo, pilot in human, safety/efficacy, etc.). Flora Pharma expects to fast track traditional FDA and NHS timelines by running phase trials in parallel (in vitro, in vivo, pilot in human, safety/efficacy, etc.).
Cannabis Law Report
JANUARY 20, 2022
First, a manufacturer can make an independent GRAS conclusion by determining a substance is generally recognized, “among experts qualified by scientific training and experience to evaluate its safety.” Delta-8 THC and other Artificially Derived Cannabinoids. 21 CFR 170.230, 170.235, and 170.255.
Expert insights. Personalized for you.
52 
Let's personalize your content